Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Everest Medicines Announces the Launch of VELSIPITY® in the Guangdong-Hong Kong-Macau Greater Bay Area, Offering a New Option for Moderately to Severely Active Ulcerative Colitis Patients
2024-10-25 07:40
Volpara Health Surpasses 300 Peer-Reviewed Papers
2024-10-25 00:00
Frost & Sullivan Honors Industry Leaders with Prestigious 2024 Best Practices Awards
2024-10-24 22:00
EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs
2024-10-24 21:05
Besmile Announces RMB 1 Million Donation to Support Shanghai 9th People's Hospital's Dental Service Development
2024-10-24 20:20
The 2024 Seminar on International Communication of Chinese Medicine and Yi Medicine Big Health Industry Development Promotion Conference Held in Chuxiong, Yunnan Province
2024-10-24 15:48
Pierre Fabre announce 1st Patient Dosed in Phase I/II of PFL-002/VERT-002, a targeted therapy in NSCLC with MET Alterations
2024-10-24 15:15
Founder of Hua Medicine Dr. Li CHEN was awarded the "C.C. Tan Life Science Industrialization Award"
2024-10-24 13:16
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation
2024-10-24 08:08
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
2024-10-24 06:02
Caliway Completed CBL-514 Phase 2b Study (CBL-0205) for Subcutaneous Fat Reduction
2024-10-24 01:42
CorDx Selects MasterControl to Streamline Life Science Quality and Manufacturing Processes Globally
2024-10-23 23:17
CCTV+: Explore the Wizard of Oz in Jiangzhong Pharmaceutical Valley
2024-10-23 15:38
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
2024-10-23 15:11
Australia's Healthcare Innovators in Stroke and Paediatric Care Honoured at 2024 Challenger Summit
2024-10-23 09:29
Harnessing Generative AI in Healthcare and Improving Cardiometabolic Health with Precision Medicine: Key Opportunities and Insights
2024-10-22 22:51
Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
2024-10-22 18:57
World Psoriasis Day 2024: Psoriatic Disease and Family--Standing Together in Support and Understanding
2024-10-22 16:00
Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON® Global Phase 3 NefIgArd Clinical Trial Published in "Kidney 360" Magazine
2024-10-22 07:40
Moleac Announces PT Ferron Par Pharmaceuticals as New Exclusive Partner in Indonesia
2024-10-21 22:20
1
5
6
7
8
9
531